期刊
JOURNAL OF CLINICAL MEDICINE
卷 4, 期 5, 页码 858-873出版社
MDPI AG
DOI: 10.3390/jcm4050858
关键词
atopic dermatitis; eczema; biomarker; translational revolution; T-cells; intrinsic; extrinsic; immune phenotype
资金
- Geoffrey Dowling Fellowship, a grant from the British Association of Dermatologists (United Kingdom)
Atopic dermatitis (AD) is the most common inflammatory skin disease. Recent research findings have provided an insight into the complex pathogenic mechanisms involved in this disease. Despite a rising prevalence, effective and safe therapeutics for patients with moderate-to-severe AD are still lacking. Biomarkers of lesional, nonlesional skin, and blood have been developed for baseline as well as after treatment with broad and specific treatments (i.e., cyclosporine A and dupilumab). These biomarkers will help with the development of novel targeted therapeutics and assessment of disease reversal, with the promise of a more personalized treatment approach. Since AD involves more than one subtype (i.e., intrinsic/extrinsic, pediatric/adult, etc.), these molecular fingerprints needs to be validated in all subpopulations with AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据